Stock Events

Stock Events

Avalo Therapeutics (AVTX) Q2 2025 Earnings

12MayConfirmed

Q3 2024

Q4 2024

Q1 2025

Q2 2025

-14.07

-9.44

-4.8

-0.17

Details

Expected EPS

-1.332

Actual EPS

-1.25

Surprise EPS

0.08

Surprise Percent

+6.16%

Description

Avalo Therapeutics (AVTX) has reported earnings of -1.25 per share for Q2 2025.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.